South America Medical Affairs Outsourcing Market is expected to reach US$ 157.45 million by 2027

PRESS RELEASE BY The Insight Partners 06 Oct 2021

Share this press on

Pharmaceutical Segment is Expected to be Fastest Growing During the Forecast Period for SAM Region

According to The Insight Partners market research study on “SAM Medical Affairs Outsourcing Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Services and Application” is expected to reach US$ 157.45 million by 2027 from 78.83 US$ million in 2020. The market is estimated to grow at a CAGR of 10.4% from 2020 to 2027. The report provides trends prevailing in the SAM medical affairs outsourcing market along with the drivers and restraints pertaining to the market growth. Outsourcing activities becoming more popular and R&D spending is increasing is the major factor driving the growth of the SAM medical affairs outsourcing market. However, issues associated with drug development and clinical trials going up hinders the growth of SAM medical affairs outsourcing market.

 SAM medical affairs outsourcing market is segmented into services, application, and country. The SAM medical affairs outsourcing market, by services, is segmented into medical writing and publishing, medical monitoring, medical science liaisons (MSLs), medical information, and others. The medical writing and publishing segment held the largest share of the market in 2019. Based on application, the SAM medical affairs outsourcing market is segmented into pharmaceutical, biopharmaceutical, and medical devices. The medical devices market is further segmented into therapeutic medical devices, and diagnostic medical devices. The pharmaceutical segment held the largest share of the market in 2019. Based on country, the SAM medical affairs outsourcing market is segmented into Brazil, Argentina, and rest of SAM. Brazil held the largest market share in 2019.

On February 26, 2020, the first case of COVID-19 was detected in Brazil's São Paulo. Since then, the governments in this region have taken various steps to protect their people and reduce the spread of COVID-19. By July 26, Latin America was the region with the highest number of reported cases worldwide, accounting for more than a quarter of the world's cases. South America registered 16,810,346 cases as of February 12, 2021. On June 11, the Government of Sao Paulo, Brazil's Instituto Butantan, signed an agreement with the Chinese laboratory Sinovac Biotech to develop an experimental vaccine against COVID-19. On December 10, President Alberto Fernández launched a national vaccination initiative to distribute 60 million doses in the first six months of 2021. Older people, health care staff, and military personnel will be among the first to obtain immunization. The President also announced an initial procurement of 600,000 Russian Sputnik V vaccine doses to vaccinate 300,000 Argentinians.

Outsourcing is very local in Latin America. Latin America has always been known for its legal and regulatory knowledge, language skills, and compatible time zone with America. Latin America is not caught up with inflation regarding total cost, which promotes a powerful value proposition of providing cost-effective services. When it comes to Spanish and Portuguese language skills, Latin America is probably the only region globally that offers the combination of language skills at scale plus cost savings. This works in favor of US markets due to the huge Spanish population present in the US. Global companies are gaining several regional and business opportunities, especially in large countries such as Brazil and Argentina, where the domestic market is also large (nearly 60–70%). With established regional markets and promises of lower costs, Latin America is considered the fastest-growing destination for offshore services in the healthcare industry.

ICON PLC, IQVIA Inc, PAREXEL INTERNATIONAL CORPORATION, PPD Inc, Syneos Health, UDG and Healthcare plc. are among the leading companies in the SAM medical affairs outsourcing market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, ICON plc, launched Accellacare a global clinical research network offering patients easier and faster access to creative treatments and offering customers the option to deploy decentralized trials.       

Contact Us
Phone: +1-646-491-9876


Download Free PDF Brochure